| Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$9,795 |
Update - Notification of buy-back - ORI
|
24 Mar 2026 8:20AM |
$18.930 |
$21.140 |
risen by
11.67%
|
|
| Objective Corporation Limited (OCL) ORDINARY FULLY PAID |
Information Technology |
$1,085 |
Update - Notification of buy-back - OCL
|
24 Mar 2026 8:20AM |
$12.210 |
$11.300 |
fallen by
7.45%
|
|
| Bendigo and Adelaide Bank Limited (BEN) ORDINARY FULLY PAID |
Financials |
$6,250 |
Ceasing to be a substantial holder
|
24 Mar 2026 8:20AM |
$10.090 |
$10.780 |
risen by
6.84%
|
|
| Nordic Resources Limited (NNL) ORDINARY FULLY PAID |
Materials |
$68 |
Change in substantial holding
|
24 Mar 2026 8:20AM |
$0.125 |
$0.180 |
risen by
44%
|
|
| Reliance Worldwide Corporation Limited (RWC) ORDINARY FULLY PAID |
Industrials |
$2,476 |
Update - Notification of buy-back - RWC
|
24 Mar 2026 8:20AM |
$3.030 |
$3.310 |
risen by
9.24%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$160 |
Dividend/Distribution - CLV
|
24 Mar 2026 8:20AM |
$0.745 |
$0.960 |
risen by
28.86%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,649 |
Net Tangible Asset Backing
|
24 Mar 2026 8:19AM |
$3.660 |
$4.180 |
risen by
14.21%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,518 |
Update - Notification of buy-back - KAR
|
24 Mar 2026 8:19AM |
$2.060 |
$2.135 |
risen by
3.64%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$23,141 |
Update - Dividend/Distribution - AAI
|
24 Mar 2026 8:19AM |
$79.840 |
$87.700 |
risen by
9.84%
|
|
| Perpetual Limited (PPT) ORDINARY FULLY PAID |
Financials |
$1,922 |
Change in substantial holding
|
24 Mar 2026 8:19AM |
$16.100 |
$16.620 |
risen by
3.23%
|
|
| Treasury Wine Estates Limited (TWE) ORDINARY FULLY PAID |
Consumer Staple |
$3,460 |
Ceasing to be a substantial holder
|
24 Mar 2026 8:19AM |
$3.570 |
$4.285 |
risen by
20.03%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$160 |
Clover 1H FY26 Investor Presentation
|
24 Mar 2026 8:19AM |
$0.745 |
$0.960 |
risen by
28.86%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross margin improved due to favorable customer and product mix.
- Operating costs increased to support growth.
- NPAT result of $4.2m, up from $2.4m in 1H FY25.
- Cash flow impacted by inventory build of oils against strong forecasts.
- Revenue growth driven by new customer acquisitions and product mix.
- Balance sheet remains strong with $10.3m cash and nil bank debt.
- CholineXcel® being tested for packaging and shelf-life.
- DHA and ARA growth supported by product diversification.
- Ecuador facility provides consistent supply for tuna oil requirements.
- FY26 revenue guidance is between $92 to $96m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$160 |
Clover 1H FY26 Results Announcement
|
24 Mar 2026 8:19AM |
$0.745 |
$0.960 |
risen by
28.86%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- Clover Corporation reported a strong performance for the first half of FY26 with revenue of $44.1 million, a significant increase from $37.6 million in 1H FY25.
- The company's gross margin improved to 35.6%, an 850 basis point increase from the previous year.
- Clover's EBITDA rose to $6.9 million, up from $4.3 million in the same period last year.
- Net Profit After Tax (NPAT) increased to $4.2 million compared to $2.4 million in 1H FY25.
- Clover's Board declared a fully franked interim dividend of 1.0 cent per share.
- The company is actively expanding its product portfolio and market reach, particularly in human nutrition segments including seniors, toddlers, and adult nutrition.
- Strategic investments and collaborations, such as with Melody Dairies and tuna oil extraction in Ecuador, are contributing to Clover's growth and diversification.
- Clover is working on the registration and approval of its DHA emulsion, Premneo, across various global markets.
- The revenue guidance for FY26 is projected between $92 and $96 million.
- Clover continues to innovate with new products like CholineXcel® and diversified DHA formulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$198 |
Update - Notification of buy-back - CAA
|
24 Mar 2026 8:19AM |
$10.870 |
$12.400 |
risen by
14.08%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$160 |
Clover 1H FY26 Report and Accounts
|
24 Mar 2026 8:19AM |
$0.745 |
$0.960 |
risen by
28.86%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- Clover Corporation reported a 17% revenue increase to $44.1 million for 1H FY26.
- Net profit after tax rose by 90% to $4.2 million.
- EBITDA improved to $6.9 million due to strategic initiatives.
- The company is focusing on product diversification and market expansion.
- An interim dividend of 1.00 cent per share was declared.
- Revenue projection for FY26 is between $92 to $96 million.
- Operational improvements included enhanced manufacturing efficiencies.
- Clover continues to innovate with new product solutions such as non-allergenic powders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$4,501 |
Becoming a substantial holder
|
24 Mar 2026 8:19AM |
$0.720 |
$0.920 |
risen by
27.78%
|
|
| SEEK Limited (SEK) ORDINARY FULLY PAID |
Communication Services |
$5,026 |
Ceasing to be a substantial holder
|
24 Mar 2026 8:18AM |
$14.670 |
$14.070 |
fallen by
4.09%
|
|
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,270 |
Becoming a substantial holder
|
24 Mar 2026 8:18AM |
$3.090 |
$3.240 |
risen by
4.85%
|
|
| Desert Metals Limited (DM1) ORDINARY FULLY PAID |
Materials |
$5 |
Commences 2,000m aircore drilling at Tiogo gold prospect
|
24 Mar 2026 8:18AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
DM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Desert Metals initiated a 2,000m aircore drilling program at Tiogo.
- Targeting a 900m untested corridor between previous high-grade intercepts.
- Phase 1 is part of a larger 6,000m drilling program in 2026.
- The drilling program is expected to complete in two weeks.
- Results expected in April 2026, with assays through Chrysos PhotonAssay.
- Tiogo is located 30km from Perseus Mining’s Sissingué gold mine.
- GAIP survey confirmed a +4km anomaly at Tiogo.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,846 |
Update - Notification of buy-back - DNL
|
24 Mar 2026 8:18AM |
$2.910 |
$3.330 |
risen by
14.43%
|
|
| Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$17 |
BM8 Unlocks Critical Metals Potential at Bleiberg
|
24 Mar 2026 8:18AM |
$0.064 |
$0.076 |
risen by
18.75%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Battery Age Minerals Ltd has commenced a maiden drilling program in the historic Bleiberg mining district, confirming a zinc-lead-germanium system.
- Higher-grade mineralization was identified at the Rubland target, including 2.5m @ 3.96% Zn+Pb.
- The exploration program consisted of six diamond drill holes totaling 1,685 meters across the Rubland and Tschöklnock targets.
- The company aims to focus future exploration on historically productive areas within the Bleiberg complex.
- Battery Age Minerals plans to engage with local stakeholders to align with the European Union’s Critical Raw Materials Act framework.
- The Bleiberg district is historically significant with approximately 700 years of mining activity, previously known for high-grade germanium concentrates.
- The company currently holds a 51% interest in the Bleiberg JV, with potential to increase to 80% by completing further expenditure and feasibility studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$270 |
Change of Director's Interest Notices
|
24 Mar 2026 8:18AM |
$0.530 |
$0.560 |
risen by
5.66%
|
|
| Stepchange Holdings Limited (STH) ORDINARY FULLY PAID |
Information Technology |
$26 |
Update - Notification of buy-back - STH
|
24 Mar 2026 8:18AM |
$0.110 |
$0.155 |
risen by
40.91%
|
|
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$8 |
Letter to Ineligible Shareholders
|
24 Mar 2026 8:18AM |
$0.006 |
$0.005 |
fallen by
9.09%
|
|
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$8 |
Letter to Eligible Shareholders
|
24 Mar 2026 8:18AM |
$0.006 |
$0.005 |
fallen by
9.09%
|
|
Call 1300 880 160
Start a chat
Schedule a call
